Pharmacology of N-type Ca2+ channels distributed in cardiovascular system (Review)

International Journal of Molecular Medicine

Volumn 3, Issue 5, 1999, Pages 455-466

  Uneyama, Hisayuki ^a   Takahara, Akira ^b   Wakamori, Minoru ^a   Mori, Yasuo ^b   Yoshimoto, Ryota ^a,b  

^a AJINOMOTO CO INC   (Japan)

^b NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

Author keywords

Cilnidipine; Hypertension; N type Ca2+ channel; Pain; SNX 111

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CILNIDIPINE; DIHYDROPYRIDINE DERIVATIVE; MOLLUSC VENOM; PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CHEMISTRY; CLASSIFICATION; DRUG EFFECT; HUMAN; INNERVATION; METABOLISM; MOLECULAR GENETICS; NERVE ENDING; RAT; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; AUTONOMIC NERVOUS SYSTEM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; DIHYDROPYRIDINES; HUMANS; MOLECULAR SEQUENCE DATA; MOLLUSK VENOMS; NERVE ENDINGS; PEPTIDES; RATS;

EID: 0033127770     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.3.5.455     Document Type: Article

References (107)

1. Godfraind T, Miller R and Wibo M: Calcium antagonism and calcium cnlry blockade. Pharmacol Rev 38: 321-416, 1986.
2. 2+ cliannels. Trends Pharmacol Sei 12: 349-354, 1991.
3. 2+ channels. J Biol Chcm 267: 1403-1406, 1992
4. 2+ channels in evoked release of norcpincphrine from sympathetic neurons. Science 239: 57-61, 1988.
5. Hachinski VC, Wilson JX, Smith KE and Cechctto DF: Effect of ace on autonomie and cardiac responses in a rat stroke model. Arch Neural 49: 690-696, 1992.
6. Wilson TW and Quest DW: Comparative pharmacology of calcium antagonists. Can J Cardiol 11: 243-249, 1995.
7. Goldbourt U, Behar S, Reicher-Reiss H, Zion M, Mandelzweig L and Kaplinsky E: Early administration of nifcdipine in suspected acute myocardial infarction: the secondary prevention reinfarction Israel nifcdipine trial 2 study. Arch Intern Med 153: 345-353, 1993.
8. Hospno M, Dozen M, Hiruma T, Fujii S, Watanabe K and Hayashi Y: Changes in heart rate and plasma norepincphrinc level of conscious spontaneously hypertensive rats treated with dlnidipinc (FRC-8653). Jpn Pharmacol Ther 23: 3029-3040, 1995.
9. Saihara S, Sumio M, Hosono M, Hayashi Y, Kitamura Y and Hashimoto S: Effect of FRC-8653 (cilnidipinc) on blood pressure changes during the cold pressor test. Jpn Pharmacol Thcr 21 (Suppl): 271-276, 1993.
10. Olivera BM: Calcium channel diversity and neurotransmitter release: the ω-conotoxins and ω-asatoxins. Annu Rev Biochcm 63:823-867, 1994.
11. Miljanich GP and Ramachandran J: Antagonists of neuronal calcium channels: structure, function, and therapeutic implications. Annu Rev Pharmacol Toxicol 35: 707-734, 1995.
12. Tsicn RW, Lipscombe D, Madison DV, Blcy KR and Fox AP: Multiple types of neuronal calcium channels and their selective modulation. Trends Neurosci 10:431-438, 1988.
13. Nowycky MC, Fox AP and Tsicn RW: Three types of neuronal calcium channel with different calcium agonist sensitivity. Nature 316:440-443, 1985.
14. Fox AP, Nowycky MC and Tsien RW: Single-channel recordings of three types of calcium channels in chick sensory neurones. J Physiol 394: 173-200, 1987.
15. Llinas R, Sugimori M, Lin JW and Cherkscy B: Blocking and isolation of a calcium channel from neurons in mammals and ccphalopods utilizing a toxin fraction (FTX) from funnel-web spider poison. Proc Nail Acad Sei USA 86: 1689-1693, 1989.
16. 2+ channel in vertebrate sensory neurones. Nature 310:501-502, 1984.
17. 2+-dependent burst firing in GABAergic neurons of rat thalamic rcticular nucleus. J Neurosci 12: 3804-3817, 1992.
18. Boland LM, Morrill JA and Bean BP: ω-conotoxin block of N-type calcium channels in frog and rat sympathetic neurons. J Neurosci 14: 5011-5027, 1994.
19. Hillman D, Chen S, Aung TT, Cherksey B, Sugimori M and Llinas RR: Localization of P-type calcium channels in the central nervous system. Proc Natl Acad Sei USA 88: 7076-7080, 1991.
20. Mintz I, Venema V, Swiderek K, Lee T, Bean B and Adams M: P-type calcium channels blocks by the spider toxin ω-agatoxin-IVA. Nature 355: 827-829, 1992.
21. Soong TW, Stea A, Hodson CD, Dubcl SJ, Vincent SR and Snutch TP: Structure and functional expression of a member of the low voltage-activated calcium channel family. Science 260: 1133-1136, 1993.
22. Ellinor PT, Zhang JF, Randall AD, Zhou M, Schwarz TL, Tsicn RW and Home WA: Functional expression of a rapidly inactivating neuronal calcium channel. Nature 363: 455-458, 1993.
23. 2+ channel 1 subunit. Receptors Channels 2: 255-270, 1994.
24. Wakamori M, Niidome T, Fumtama D, Fumichi T, Mikoshiba K, Fujita Y, Tanaka I, Katayaina K, Yatani A, Schwartz A and Mori Y: Distinctive functional properties of the neuronal BII (class E) calcium channel. Receptors Channels 2: 303-314, 1994.
25. Williams ME, Marubio LM, Deal CR, Hans M, Brust PF, Philipson LH, Miller RJ, Johnson EC, Harpold MM and Ellis SB: Structure and functional characterization of neuronal α1E calcium channel subtypes. J Biol Chem 269: 22347-22357, 1994.
26. Bourinct E, Zamponi GW, Stea A, Soong TW, Lewis BA, Jones LP, Yuc DT and Snutch TP: The αlE calcium channel exhibits permeation properties similar to low-voltagc-activatcd calcium channels. J Ncurosci 16:4983-4993, 1996.
27. Stephens GJ, Page KM, Burley JR, Bcrrow NS and Dolphin AC: Functional expression of rat brain cloned αIE calcium channels in COS-7 cells. Pflugers Arch Eur J Physiol 433: 523-532, 1997.
28. Campbell KP, Lcung AT and Sharp AH: The biochemistry and molecular biolocy of the dihydropyridinc-scnsitive calcium channel. Trends Ncurosci 11: 425-430, 1988.
29. Glossmann H and Striessnig J: Molecular properties of calcium channels. Rev Physiol Biochcm Pharmacol 114: 1-105, 1990.
30. 2+ channel diversity. Annu Rev Ncurosci 17: 399-418, 1994.
31. Cattcrall WA: Structure and function of voltage-gated ion channels. Annu Rev Biochcm 64:493-531, 1995.
32. Gurnett CA and Campbell KP: Transmembrane auxiliary subunits of voltace-depcndent ion channels. J Biol Chem 271: 27975-27978, 1996.
33. 2+ channels: role in channel function. Trends Neurosci 21: 148-154, 1998.
34. Mori Y, Mikala G, Varadi G, Kobayashi T, Koch S, Wakamori M and Schwarz A: Jpn J Pharmacol 72: 83-109, 1996.
35. Mikami A, Imoto K, Tanabe T, Niidome T, Mori Y, Takeshima H, Narumiya S and Numa S: Primary structure and functional expression of the cardiac dihydropyridine-sensitivc calcium channel. Nature 340: 230-233, 1989.
36. Mori Y, Friedrich T, Kim MS, Mikami A, Nakai J, Ruth P, Bosse E, Hofmann F, Flockcrzi V, Furuichi T, Mikoshiba K, Imoto K, Tanabe T and Numa S: Primary structure and functional expression from complementary DNA of a brain calcium channel. Nature 350: 398-402, 1991.
37. 2+ channel αl subunit and the effects of a cardiac β subunit. Biochem Biophys Res Commun 196: 1170-1176, 1993.
38. Pragnell M, DC Waard M, Mori Y, Tanabe T, Snutch TP and Campbell KP: Calcium channel β-subunit binds to a conserved motif in the I-II cytoplasmic linker of the αl-subunit. Nature 368: 67-70, 1994.
39. 2+ channel regulation by a conserved β subunit domain. Neuron 13: 495-503, 1994.
40. Westenbrock RE, Hell JW, Warner C, Dubel SJ, Snutch TP and Catterall WA: Biochemical properties and subccllular distribution of an N-type calcium channel alpha 1 subunit. Neuron 9: 1099-1115, 1992.
41. Takahashi T and Momiyama A: Different types of calcium channels mediated central synaptic transmission. Nature 366: 156-158, 1993.
42. Borst JB and Sakmann B: Calcium influx and transmitter release in a fast CNS synapse. Nature 383: 431-434, 1996.
43. Narahashi T, Tsunoo A and Yoshii M: Characterization of two types of calcium channels in mouse ncuroblastoma cells. J Physiol 383: 231-249, 1987.
44. Akaike N, Kostyuk PG and Osipchuk YV: Dihydropyridinc-scnsitive low-threshold calcium channels in isolated rat hypothalamic neurones. J Physiol 412: 181-195, 1989.
45. Kcrr L and Yoshikami D: A venom peptide with a novel prcsynaptic blocking action. Nature 308: 282-284, 1984.
46. Olivera B, Cruz L, DC Santos V, Le Cheminant G, Griffin D, Zcikus R, Mclntosh J, Galycan R, Varga J, Gray W and Rivicr J: Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using co-conotoxin from Conns magus Venom. Biochemistry 26: 2086-2090, 1987.
47. McClcskcy E, Fox A, Fcldman D, Cruz L, Olivera B and Tsicn R: ω-conotoxin: direct and persistent blockade of specific types of calcium channels in neurons but not muscle. Proc Natl Acad Sei USA 84: 4311-4327, 1987.
48. Slier E, Pandiclla A and Clemcnti F: Omcga-conotoxin binding and effects on calcium channel function in human ncuroblastoma and rat pheochromocytoma cell lines. FEBS Lett 235: 178-182, 1988.
49. Kasai H and Aosaki T: Divalent cation dependent inactivation of the high-voltage-activated Ca-channel current in chick sensory neurons. Pflugers Arch 411: 695-697, 1988.
50. Plummer M, Logothetis D and Hess P: Elementary properties and pharmacological sensitivities of calcium channels in mammalian peripheral neurons. Neuron 2: 1453-1463, 1988.
51. Marwick C: Nature's asents help heal humans - some now take steps to reciprocate. JAMA 279: 1679-1681, 1998.
52. Tytgat J, Pauwels P, Vercecke J and Carmcliet E: Flunarizine inhibits a high-threshold inactivating calcium channel (N-typc) in isolated hippocampal neurons. Brain Res 549: 112-117, 1991.
53. 2+ current by cilnidipine (FRC-8653) in acutely dissociated rat sympathetic neurones. Br J Pharmacol 122: 37-42, 1997.
54. 2+ channel blocking actions of NS-7, a novel neuroprotcctive acent, in NG108-15 cells. Eur J Pharmacol 336: 283-290, 1997.
55. 2+ influx in prcsynaptic nerve terminals. Br J Pharmacol 101: 45-48, 1990.
56. Keith RA, Mangano TJ, De Fco PA, Horn MB and Salama AI: Actions of neomycin on neuronal L-, N-, and non-L/non-N-type voltase-scnsitive calcium channel responses. J Mol Ncurosci 3: 147-154, 1992.
57. ++ channels. J Pharmacol Exp Ther 271: 1348-1352, 1994.
58. ++ channel in rat dorsal root ganalion neurons. J Pharmacol Exp Ther 280: 1184-1191, 1997.
59. Uncyama H, Uchida H, Yoshimoto R, Ucno S, Inouc K and Akaike N: Effects of a novel antihypertcnsive drug, cilnidipine, on the catecholaminc secretion from the differentiated PC12 cells. HypcrtcnsionSl: 1195-1199, 1998.
60. El-Din MM and Malik K: Differential effect of ω-conotoxin on release of the adrcnergic transmitter and the vasoconstrictor response to noradrcnaline in the rat isolated kidney. Br J Pharmacol 94: 355-362, 1988.
61. Clasbrummcl B, Osswald H and Illcs P: Inhibition of noradrcnaline release by ω-conotoxin GVIA in the rat tail artery. Br J Pharmacol 96: 101-110,1989.
62. Pruneau D and Angus J: ω-conotoxin GVIA is a potent inhibitor of sympathetic neurogenic responses in rat small mesenteric arteries. Br J Pharmacol 100: 180-184, 1990.
63. Hosono M, Fujii S, Hiruma T, Watanabc K, Hayashi Y, Ohnishi H, Takata Y and Kato H: Inhibitory effect of cilnidipine on vascular sympathetic ncurotransmission and subsequent vasoconstriction in spontaneously hypertensive rats. Jpn J Pharmacol 69: 127-134, 1995.
64. Hong S, Roan Y and Chang C: Inhibition of neuromuscular transmission in the myenteric plexus of guinea-pig ilcum by ω-conotoxins GVIA, MVIIA, MVIIC and SVIB. Br J Pharmacol 118:797-803, 1996.
65. Fabi F, Chiavarelli M, Argiolas L, Chiavarelli R and Del Basso P: Evidence for sympathetic neurotransmission through prcsynaptic N-type calcium channels in human saphenous vein. Br J Pharmacol 110: 338-342, 1993.
66. Lancer S: Prcsynaptic rcsulation of the release of catecholamincs. Pharmacol Rev 32: 337-362, 1981.
67. Bochm S and Huck S: Receptors controlling transmitter release from sympathetic neurons in vitro. Prog Ncurobiol 51: 225-242, 1997.
68. Lipscombe D, Kongsamut S and Tsicn R: α-adrenergic inhibition of sympathetic neurotransmittcr release, mediated by modulation of N-typc calcium-channel gatins. Nature 340: 639-642, 1989.
69. Kongsamut S, Lipscombe D and Tsicn W: The N-type Ca channel in frog sympathetic neurons and its role in α-adrencrgic modulation of transmitter release. Ann NY Acad Sei 560: 312-333, 1989.
70. 2-adrenoceptors in chick sympathetic neurons. Naunyn Schmicdcbergs Arch Pharmacol 345: 606-609, 1992.
71. Ikcda S: Voltage-dependent modulation of N-type calcium channels by G-protcin By subunits. Nature 380: 255-258. 1996.
72. 2+ currents and synaptic transmission in cultured rat hippocampal pyramidal neurones. J Physiol 435: 373-393, 1991.
73. 2+ channel current through a pertussis toxin-sensitive G protein in rat phcochromocytoma-dcrivcd PC12 cells. J Clin Invest 98: 14-17, 1996.
74. Zhu Y and Yakcl J: Calcinctirin modulates G protein-mediated inhibition of N-type calcium channels in rat sympathetic neurons. J Neurophysiol 78: 1161-1169, 1997.
75. 3H]acctylchoIinc from the mycntcric plexus, phrenic nerve and ncocortcx of rats. Naunyn Schmiedebcrgs Arch Pharmacol 341: 288-294, 1990.
76. Boot J: Differential effects of ωconotoxin GVIA and MVIIC on nerve stimulation induced contractions of guinea-pic ileum and rat vas deferens. Eur J Pharmacol 258: 155-158, 1994.
77. 2+ channel modulators on vasially induced bronchoconstriction in the guinea-pis. Eur J Pharmacol 219: 123-128, 1992.
78. Ron L, Furukawa Y, Murakami M, Takayama S, Inouc Y, Sawaki S and Chiba S: Inhibition by ω-conotoxin GVIA of the chronotropic responses to sympathetic and parasympalhetic nerve stimulation in the isolated, blood-perfused atrium of the dog. J Auton Pharmacol 13: 257-265, 1993.
79. Albillos A, Artalejo A, Lopcz M, Gandia L, Garcia A and Carbone E: Calcium channel subtypes in cat chromaffin cells. J Physiol 477: 197-213, 1994.
80. Lopez M, Villarroya M, Lara B, Sierra R, Albillos A, Garcia A and Gandia L: Q- and L-typc channels dominate the control of secretion in bovine chromaffin cells. FEBS Lett 349: 331-337, 1994.
81. Gandia L, Borges R, Albillos A and Garcia A: Multiple calcium channel subtypes in isolated rat chromaffin cells. Pfiuccrs Arch Pharmacol 430: 55-63, 1995.
82. Kim S, Lim W and Kim J: Contribution of L- and N-type calcium currents to exocytosis in rat adrenal medullary chromaffin cells. Brain Res 675: 289-296, 1995.
83. 2+ currents are found in bovine chromaffin cells: facilitation is due to the recruitment of one type. J Physiol 432: 681-707, 1991.
84. 2+ current in bovine chromaffin cells that is not of the 'classic' N type. Neuron 8: 85-95, 1992.
85. 2+ channel tricccr secretion with different efficacies in chromaffin cells. Nature 367: 72-76, 1994.
86. Takeuchi A, Kimura T and Satoh S: Effects of nifcdipine and Bay-K-8644 on the release of catecholamincs from the dog adrenal gland in response to splanchnic nerve stimulation. Clin Exp Pharmacol Physiol 20: 35-39, 1993.
87. Kimura T, Takeuchi A and Satoh S: Inhibition by ω-conotoxin GVIA of adrenal catccholamine release in response to endogenous and exocenous acethylcholinc. Eur J Pharmacol 264: 169-175, 1994.
88. 2+ channel blockcr, on adrenal catccholamine secretion in anesthetized docs. J Cardiovasc Pharmacol 32: 479-484, 1998.
89. Herd J: Cardiovascular response to stress. Physiol Rev 71: 305-330, 1991.
90. Hosono M, Hiruma T, Watanabe K, Hayashi Y, Ohnishi H, Takata Y and Kalo II: Inhibitory effect of cilnidipinc on prcssor response to acute cold stress in spontaneously hypertensive rats. Jpn J Pharmacol 69: 119-125, 1995.
91. Chiba K, Hayashi Y, Hisa H, Kusaba-Suzuki M and Satoh S: Effects of a novel α1-adrcnoccptor antagonist, SGB-1534, on adrcnaeically induced renal vasoconstriction in docs. Eur J Pharmacol 176: 263-269, 1990.
92. Ogawa N, Kushida H and Satoh S: Effect of verapamil on renal vasoconstriction induced by angiotcnsin II, norepinephrine or renal nerve stimulation in anesthetized dogs. Arch Int Pharmacodyn Thcr 268: 113-121, 1984.
93. Imagawa J, Kusaba-Suzuki M and Satoh S: Preferential inhibitory effect of nifedipine on angiotensin II-induced renal vasoconstriction. Hypertension 8: 897-903, 1986.
94. Ogasawara A, Hisa H and Satoh S: An intracellular calcium release inhibitor TMB-8 suppresses renal nerve stimulation-induced antinatriuresis in dogs. J Pharmacol Exp Ther 264: 117-121, 1993.
95. Michalcwicz L and Messerli F: Cardiac effects of calcium antagonists in systemic hypertension. Am J Cardiol 79: 39-46, 1997.
96. Malmberg AB and Yaksh TL: Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N- and P-type channels inhibits formalin-induced nociception. J Neurosci 14: 4882-4890, 1994.
97. Touw K, Haywood J, Schafter R and Brody M: Contribution of the sympathetic nervous system to vascular resistance in conscious young and adult spontaneously hypertensive rats. Hypertension 2: 408-418, 1980.
98. Lokhandwala M and Eikcnburg D: Presynaptic receptors and alterations in norepinephrine release in spontaneously hyperJcnsive rats. Life Sei 33: 1527-1542, 1983.
99. Lee R, Trigglc C, Cheung D and Coughlin M: Structural and functional consequence of neonatal sympathectomy on the blood vessels of spontaneously hypertensive rats. Hypertension 10: 328-338, 1987.
100. Dictz R, Schomig A, Rascher W, Strasser R, Luth JB, Ganten U and Kubler W: Contribution of the sympathetic nervous system to the hypertensive effect of a high sodium diet in stroke-prone spontaneously hypertensive rats. Hypertension 4: 773-781, 1982.
101. Pruneau D and Belichard P: Haemodynamic and humoral effects of ω-conotoxin GVIA in normotensive and spontaneously hypertensive rats. Eur J Pharmacol 2.11: 329-335, 1992.
102. Kukreja RS, Datta BN and Chakravarti RN: Catccholamine-induced aggravation of aortic and coronary atherosclerosis in monkey. Atherosclerosis 40: 291-298, 1981.
103. Yamori T, Massayuki M, Nara Y and Horic R: Catecholamine-induced polyploidization in vascular smooth muscle cells. Circulation 75 (Suppl I): 192-195, 1987.
104. Yu S-M, Tsai S-Y, Guh J-H, Ko F-N, Teng C-M and Ou JT: Mechanism of catccholamine-induced proliferation of vascular smooth muscle cells. Circulation 94: 547-554, 1996.
105. Meisel SR, Kutz I, Dayan KI, Pauzner H, Chctboun I, Arbel Y and David D: Effect of Iraqi missile war on incidence of acute myocardial infarction and sudden death in Israeli civilians. Lancet 338: 660-661, 1991.
106. Suzuki S, Sakamoto S, Koide M, Fujita H, Sakuramoto H, Kuroda T, Kintaka T and Matsuo T: Hanshin-Awaji earthquake as a trieger for acute myocardial infarction. Am Heart J 134: 974-977, 1997.
107. Takahara A, Dohmoto H, Hisa H, Satoh S, Yoshimoto R: Cilnidipine attenuates renal nerve stimulation-induced renal vasoconstriction and antinatriuresis in anesthetized dogs. Jpn J Pharmacol 75: 27-32, 1997.